Cognitive behavioural therapy (brief versus standard duration) for schizophrenia

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 4, 2014, Pages

  Naeem, Farooq ^a   Farooq, Saeed ^b   Kingdon, David ^c  

^a QUEEN S UNIVERSITY   (Canada)

^b STAFFORDSHIRE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITIVE BEHAVIORAL THERAPY; COMPARATIVE STUDY; HUMAN; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; TREATMENT DURATION; COGNITIVE THERAPY; PROCEDURES; PSYCHOTHERAPY; TIME;

COGNITIVE THERAPY; HUMANS; PSYCHOTHERAPY, BRIEF; SCHIZOPHRENIA; TIME FACTORS;

EID: 84901505815     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010646.pub2     Document Type: Review

References (46)

1. Kemp R, Kirov G, Everitt B, Hayward P, David A. Randomised controlled trial of compliance therapy. 18-month follow-up. British Journal of Psychiatry 1998;172:413-9.
2. Levine J, Barak Y, Granek I. Cognitive group therapy for paranoid schizophrenics: applying cognitive dissonance. Journal of Cognitive Psychotherapy 1998;12:3-12.
3. Lewis S, Tarrier N, Haddock G, Bentall R, Kinderman P, Kingdon D, et al.Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes. British Journal of Psychiatry 2002;43:91-7.
4. O'Donnell C, Donohoe G, Sharkey L, Owens N, Migone M, Harries R, et al.Compliance therapy: a randomised controlled trial in schizophrenia. BMJ 2003;327:834-7.
5. Turkington D, Kingdon D. Cognitive-behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry 2000;177:101-6.
6. Turkington D, Kingdon D, Turner T, Insight into Schizophrenia Research Group. Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry 2002;180:523-7.
7. Wykes T, Hayward P, Thomas N, Green N, Surguladze S, Fannon D, et al.What are the effects of group cognitive behaviour therapy for voices? A randomised control trial. Schizophrenia Research 2005;77:201-10.
8. Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313(7066):1200.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th Edition. Washington, DC: APA, 1994.
10. Bland JM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600.
11. Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, et al.The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use [Apercu sur la problematique des indices d'efficacite therapeutique, 3: comparaison des indices et utilisation. Groupe d'etude des Indices d'efficacite]. Therapie 1999;54(4):405-11. [PUBMED: 10667106].
12. Bond F, Dryden W (editors). Handbook of Brief Cognitive Behaviour Therapy. Chichester: John Wiley & Sons, 2002.
13. Buckley LA, Pettit T, Adams CE. Supportive therapy for schizophrenia. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI:; PUBMED: 17636772].
14. Churchill R, Hunot V, Corney R, Knapp M, McGuire H, Tylee A, Wessely S. A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. Health Technology Assessment 2001; Vol. 5, issue 35.
15. Cully JA, Teten AL. A Therapist's Guide to Brief Cognitive Behavioral Therapy. Houston: Department of Veterans Affairs South Central MIRECC, 2008.
16. Deeks J. Issues in the selection for meta-analyses of binary data. Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28. Cape Town: The Cochrane Collaboration, 2000.
17. Divine GW, Brown JT, Frazier LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7(6):623-9.
18. Donner A, Klar N. Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine 2002;21(19):2971-80.
19. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
20. Elbourne D, Altman DG, Higgins JPT, Curtina F, Worthingtond HV, Vaile A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
21. Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology 2006;59(1):7-10.
22. Guaiana G, Morelli AC, Chiodo D. Cognitive behaviour therapy (group) for schizophrenia. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI:].
23. Gulliford MC. Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149(9):876-83.
24. Hazlett-Stevens H, Craske MG. Brief cognitive-behavioral therapy: definition and scientific foundations. In: Bond F, Dryden W (editors) editor(s). Handbook of Brief Cognitive Behaviour Therapy. Chichester: John Wiley & Sons, 2002:1-20.
25. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
26. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
27. Hutton JL. Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials. British Journal of Haematology 2009;146(1):27-30.
28. Jones C, Campbell C, Cormac I, Hacker D, Meaden A. Cognitive behaviour therapy versus standard care for schizophrenia. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI:].
29. Jones C, Cormac I, Campbell C, Meaden A, Hacker D. Cognitive behaviour therapy versus specific pharmacological treatments for schizophrenia. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI:].
30. Jones C, Hacker D, Cormac I, Meaden A, Irving CB. Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI:].
31. Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi-Health Systems, 1986.
32. Kingdon D, Kirschen H. Who does not get cognitive-behavioral therapy for schizophrenia when therapy Is readily available?. Psychiatric Services 2006;57:1792-4.
33. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of Brief Psychiatric Rating Scale scores. British Journal of Psychiatry 2005;187:366-71. [PUBMED: 16199797].
34. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR. What does the PANSS mean?. Schizophrenia Research 2005;79(2-3):231-8. [PUBMED: 15982856].
35. Leucht S, Engel RR, Bauml J, Davis JM. Is the superior efficacy of new generation antipsychotics an artifact of LOCF?. Schizophrenia Bulletin 2007;33(1):183-91. [PUBMED: 16905632].
36. Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249-52.
37. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiologic Reviews 2008;30(1):67-76.
38. McIntosh A, Conlon L, Lawrie S, Stanfield AC. Compliance therapy for schizophrenia. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI:].
39. Mueser KT, McGurk SR. Schizophrenia. Lancet 2004;363(9426):2063-72.
40. NICE. Schizophrenia (update) March 2009. http://www.nice.org.uk/CG82 (accessed 13 Dec 2011).
41. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychological Reports 1962;10:799-812.
42. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Archives of General Psychiatry 2007;64(10):1123-31.
43. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al.Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2008:359-83.
44. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PG. Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review. Health Technology Assessment 1999;3(5):iii-92.
45. Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin 2008;34(3):523-37.
46. Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El-Sayeh H, et al.Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin 2009;33(7):254-7.